tradingkey.logo


tradingkey.logo


Anbio Biotechnology

NNNN
24.470USD
+1.270+5.47%
終倀 03/30, 16:00ET15分遅れの株䟡
3.48B時䟡総額
397.37盎近12ヶ月PER


Anbio Biotechnology

24.470
+1.270+5.47%

詳现情報 Anbio Biotechnology 䌁業名

Anbio Biotechnology is a Germany-based medical device company. The Company is engaged in the development of medical technology and the provision of in vitro diagnostics (IVD) products. Its products offer solutions for over the counter (OTC) use, point-of-care (POCT) settings, and laboratory applications, ensuring that both healthcare providers and patients have access to reliable and efficient diagnostic tools in any setting. Its IVD products detect a wide range of biomarkers across critical medical fields, including infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Some of its IVD platforms: Chemiluminescence Immunoassay (ChLIA), Lateral Flow Immunoassay (LFIA), Fluorescent Immunoassay (FIA), Polymerase Chain Reaction (PCR) and Loop-mediated Isothermal Amplification (LAMP).

Anbio Biotechnologyの䌁業情報


䌁業コヌドNNNN
䌚瀟名Anbio Biotechnology
䞊堎日Feb 19, 2025
最高経営責任者「CEO」Lau (Michael)
埓業員数27
蚌刞皮類Ordinary Share
決算期末Feb 19
本瀟所圚地Friedrich-Ebert-Anlage 49
郜垂FRANKFURT AM MAIN
蚌刞取匕所NASDAQ OMX - NASDAQ BASIC
囜Germany
郵䟿番号60308
電話番号4916096247281
りェブサむトhttps://anbiobiotechnology.com/
䌁業コヌドNNNN
䞊堎日Feb 19, 2025
最高経営責任者「CEO」Lau (Michael)

Anbio Biotechnologyの経営陣


䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Michael Lau
Mr. Michael Lau
Chief Executive Officer
Chief Executive Officer
--
--
Ms. Suki Song
Ms. Suki Song
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Chris Tiantian
Mr. Chris Tiantian
Chief Business Officer
Chief Business Officer
--
--
Mr. Cany Xu
Mr. Cany Xu
Executive Director
Executive Director
--
--
Ms. Nancy Hartzler
Ms. Nancy Hartzler
Independent Director
Independent Director
--
--
Mr. Kenneth Li
Mr. Kenneth Li
Independent Director
Independent Director
--
--
Mr. David Hsu
Mr. David Hsu
Independent Director
Independent Director
--
--
䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Michael Lau
Mr. Michael Lau
Chief Executive Officer
Chief Executive Officer
--
--
Ms. Suki Song
Ms. Suki Song
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Chris Tiantian
Mr. Chris Tiantian
Chief Business Officer
Chief Business Officer
--
--
Mr. Cany Xu
Mr. Cany Xu
Executive Director
Executive Director
--
--
Ms. Nancy Hartzler
Ms. Nancy Hartzler
Independent Director
Independent Director
--
--
Mr. Kenneth Li
Mr. Kenneth Li
Independent Director
Independent Director
--
--

収益内蚳

通貚: USD曎新時刻: Tue, Jan 6
通貚: USD曎新時刻: Tue, Jan 6
FY2024
FY2023
䌚瀟から関連デヌタがただ開瀺されおいたせん。
地域別USD
䌚瀟名
収益
比率
European Union
5.62M
68.64%
South America
1.48M
18.02%
Asia Pacific
509.17K
6.22%
Other Regions
472.38K
5.77%
North America
110.51K
1.35%
事業別
地域別
䌚瀟から関連デヌタがただ開瀺されおいたせん。

株䞻

曎新時刻: Thu, Dec 4
曎新時刻: Thu, Dec 4
株䞻統蚈
皮類
株䞻統蚈
株䞻統蚈
比率
Northwestern Mutual Capital, LLC
4.78%
CVC Investment
4.78%
Geode Capital Management, L.L.C.
0.06%
他の
90.37%
株䞻統蚈
株䞻統蚈
比率
Northwestern Mutual Capital, LLC
4.78%
CVC Investment
4.78%
Geode Capital Management, L.L.C.
0.06%
他の
90.37%
皮類
株䞻統蚈
比率
Investment Advisor
4.79%
Corporation
4.78%
Investment Advisor/Hedge Fund
0.06%
他の
90.37%

機関投資家保有株


曎新時刻: Thu, Jan 1
曎新時刻: Thu, Jan 1
報告期間
機関投資家数
保有株匏数
比率
倉動額
2025Q4
12
2.17M
4.94%
+2.15M
2025Q3
8
2.13M
4.85%
+2.06M
2025Q2
5
4.27M
9.72%
+4.25M
2025Q1
5
4.27M
9.72%
+4.27M

株䞻動向


䌚瀟名
保有株匏数
比率
倉動額
倉動率
日付
Northwestern Mutual Capital, LLC
2.10M
4.78%
+2.10M
--
Feb 19, 2025
CVC Investment
2.10M
4.78%
+2.10M
--
Feb 19, 2025
Geode Capital Management, L.L.C.
25.76K
0.06%
+8.63K
+50.40%
Sep 30, 2025
UBS Financial Services, Inc.
960.00
0%
-9.73K
-91.02%
Sep 30, 2025
BNP Paribas Securities Corp. North America
2.42K
0.01%
+1.16K
+91.83%
Sep 30, 2025
Wells Fargo Advisors
100.00
0%
--
--
Sep 30, 2025
Morgan Stanley & Co. LLC
8.61K
0.02%
+8.21K
+2052.50%
Sep 30, 2025
Invesco Capital Management LLC
35.00
0%
--
--
Dec 31, 2025
Marshall Wace LLP
10.44K
0.02%
+10.44K
--
Sep 30, 2025
Millennium Management LLC
7.08K
0.02%
+7.08K
--
Sep 30, 2025
詳现を芋る

関連ETF


銘柄名
比率
デヌタなし

配圓金


過去5幎間の配圓金総支払額は 0.00 米ドルである。
日付
配圓金
暩利確定日
支払日
配圓萜ち日
デヌタなし

株匏分割


日付
配圓萜ち日
皮類
比率
デヌタなし
日付
配圓萜ち日
皮類
比率
デヌタなし
KeyAI
î™